Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myoclonus.

Melissa J Nirenberg1, Steven J Frucht

  • 1Columbia University Medical Center, Department of Neurology, 710 West 168th Street, New York, NY 10032, USA. sf216@columbia.edu.

Current Treatment Options in Neurology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point of view: Task-specific movement disorders-time for a reappraisal?

Parkinsonism & related disorders·2026
Same author

International Parkinson and Movement Disorder Society Clinical Outcome Assessments are Available in REDCap.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

A novel hierarchical framework elucidating regional differences in α-synuclein and tau co-pathology in military veterans with parkinsonism.

Journal of neuropathology and experimental neurology·2025
Same author

RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Myoclonus, dystonia and parkinsonism due to a de novo novel variant in the NUS1 gene: Furthering the epilepsy-dyskinesia spectrum - Expert commentary.

Parkinsonism & related disorders·2025
Same author

Deep Phenotyping of Musicians' Upper Limb Dystonia.

Tremor and other hyperkinetic movements (New York, N.Y.)·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Myoclonus involves sudden, brief, involuntary muscle movements. Identifying the cause and treating underlying conditions are key first steps for effective management and prognosis.

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Myoclonus is characterized by sudden, brief, shock-like involuntary muscle movements.
  • It encompasses diverse physiological and pathological processes, necessitating a systematic diagnostic approach.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for managing myoclonus.
  • To emphasize the importance of identifying the underlying etiology for effective treatment.

Main Methods:

  • Evaluation of patients with myoclonus involves identifying the underlying cause.
  • Initial treatment focuses on addressing toxic or metabolic conditions.
  • Pharmacotherapy is selected based on the probable anatomical localization of the myoclonus.

Main Results:

Related Experiment Videos

  • Treatment initiation often involves a single agent, but polytherapy is frequently required for adequate symptomatic control.
  • The variability in prognosis is directly linked to the underlying etiology of the myoclonus.

Conclusions:

  • A thorough etiological investigation is paramount in managing myoclonus.
  • Tailored pharmacotherapy, often requiring multiple agents, is essential for symptom management.
  • Prognosis is highly variable and contingent upon the specific cause of myoclonus.